Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: July 2, 2020

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Promising Results for Experimental COVID-19 Vaccine in...

Multiple Surgeries for Cleft Lip, Palate Won't Cause Major Psychological Damage

FRIDAY, July 3, 2020 -- Having multiple surgeries for cleft lip and palate doesn't appear to have a major impact on children's mental health, a new study...

Follow Exercise Guidelines and You'll Live Longer, Study Says

FRIDAY, July 3, 2020 -- Getting the recommended amount of exercise could cut your risk of early death, a new study indicates. U.S. government guidelines...

Injuries Shoot Up After Fireworks Laws Loosened in West Virginia

FRIDAY, July 3, 2020 -- West Virginia loosened fireworks sales rules in 2016. And since then, the state has seen a 40% boom in fireworks-related injuries,...

U.S. Coronavirus Hospitalizations Spiking in South, West

FRIDAY, July 3, 2020 -- As the daily toll of new coronavirus cases broke yet another record and topped 55,000 on Thursday, COVID-19 hospitalizations were also...

Thousands of Heat-Related Deaths Occur Each Year in the U.S.

THURSDAY, July 2, 2020 -- Between 1997 and 2006, 0.44 percent of U.S. deaths were attributable to heat, according to a study published in the June issue of...

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 29 to July 3,...

Some Say Allow Family Access to Dying Patients With COVID-19

THURSDAY, July 2, 2020 -- Allowing adult family member presence at the bedside of dying patients during COVID-19 is feasible, and could have multiple benefits,...

Point-Prevalence Surveys in SNFs Help Cut COVID-19 Transmission

THURSDAY, July 2, 2020 -- Conducting point-prevalence surveys in skilled nursing facilities (SNFs) can inform cohorting and infection prevention and control...

EMS Calls Down Early in COVID-19 Outbreak

THURSDAY, July 2, 2020 -- Early in the COVID-19 outbreak there was a significant decrease in the number of emergency medical services (EMS) responses across...

FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available

July 2, 2020 -- ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today...

FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation

Dublin, Ireland – 2 July 2020: Cosmo Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has approved Byfavo (remimazolam...

Blueprint Medicines Announces Submission of New Drug Application to FDA for Pralsetinib for the Treatment of Advanced RET Mutant and RET Fusion-Positive Thyroid Cancers

CAMBRIDGE, Mass., July 1, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined...

FDA Approves Dojolvi (triheptanoin) for the Treatment of Long-Chain Fatty Acid Oxidation Disorders

NOVATO, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and...

Mezzion Announces Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single Ventricle Heart Disease

SEOUL, South Korea, June 30, 2020 /PRNewswire/ -- Mezzion Pharma Co. Ltd. (140410.KQ), announced today that it has submitted a New Drug Application (NDA) to...

FDA Approves Bavencio as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Rockland, MA and New York, US, JUNE 30, 2020 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and...

FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer

South San Francisco, CA -- June 29, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug...

Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain

SAN DIEGO, June 29, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of...

Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45

CAMBRIDGE, Mass., June 26, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today...

Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US

ADELAIDE, Australia, June 24, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the New Drug Application (NDA) for E4/DRSP to...

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2

NEW YORK & MAINZ, Germany--(BUSINESS WIRE) July 01, 2020 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary data from...

INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19

PLYMOUTH MEETING, Pa., June 30, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA...

Recombinant Novel Coronavirus Vaccine (adenovirus type 5 Vector) Received Military Specially-Needed Drug Approval in China

Hong Kong, June 29, 2020 -- This announcement is made by CanSino Biologics Inc. (the “Company”) pursuant to Rule 13.09 of the Rules Governing the...

Vaxart’s COVID-19 Vaccine Selected for the U.S. Government’s Operation Warp Speed

SOUTH SAN FRANCISCO, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are...

Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol

NORTH CHICAGO, Ill., June 26, 2020 /PRNewswire/ -- Allergan, an AbbVie Company (NYSE: ABBV), and Molecular Partners (SIX: MOLN), a clinical-stage biotechnology...

Older Articles by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.